Colgate-Palmolive(US:CL)2026-01-30 12:57Financial Performance - Full year net sales increased by 1.4% to $20,382 million, compared to $20,101 million in 2024[2] - GAAP EPS for the full year declined by 25% to $2.63, primarily due to impairment charges related to the skin health business[4] - Base Business EPS increased by 3% to $3.69 for the full year[2] - Fourth quarter net sales rose by 5.8% to $5,230 million, with organic sales growth of 2.2%[6] - GAAP EPS for the fourth quarter was $(0.05), a decline of 106% due to impairment charges[5] - For the full year 2025, net sales totaled $20,382 million, a slight increase from $20,101 million in 2024[32] - The company reported a net income of $2,132 million for the full year 2025, down from $2,889 million in 2024[32] - Total operating profit for the twelve months ended December 31, 2025, was $3.306 billion, compared to $4.268 billion in 2024, reflecting ongoing challenges[38] Profitability Metrics - Gross profit for Q4 2025 was $3,146 million, with a gross profit margin of 60.2%, slightly down from 60.3% in Q4 2024[30] - Full year gross profit was $12,251 million, with a gross profit margin of 60.1%, down from 60.5% in 2024[32] - Operating profit for Q4 2025 significantly decreased to $92 million, down from $1,064 million in Q4 2024, resulting in an operating profit margin of 1.8% compared to 21.5% in the previous year[30] - The operating profit margin for the three months ended December 31, 2025, was 1.8%, down from 21.5% in 2024, indicating a substantial decline in profitability[52] - Operating profit under GAAP fell by 23% from $4,268 million in 2024 to $3,306 million in 2025[58] - Non-GAAP operating profit remained relatively stable at $4,347 million in 2025 compared to $4,353 million in 2024[58] Shareholder Returns - The company returned $2.9 billion to shareholders through dividends and share repurchases in 2025[4] Future Outlook - The company expects 2026 net sales growth of 2% to 6%, with organic sales growth projected at 1% to 4%[12] - Gross profit margin is expected to expand in 2026, with double-digit earnings per share growth anticipated on a GAAP basis[12] Market Position - Colgate's global market share in toothpaste remained strong at 41.3% year to date[9] Operational Efficiency - Selling, general and administrative expenses as a percentage of net sales increased to 39.6% in 2025 from 38.3% in 2024, indicating rising operational costs[52] - Selling, general and administrative expenses as a percentage of net sales increased from 38.5% in 2024 to 38.8% in 2025[58] Taxation - The effective tax rate for Q4 2025 was 104.7%, a substantial increase from 21.6% in Q4 2024[30] - The effective tax rate for GAAP net income increased from 22.9% in 2024 to 26.1% in 2025[60] Regional Performance - North America sales decreased by 1.5% in the three months ended December 31, 2025, while Latin America saw a significant increase of 12.8%[44] - Sales in Europe increased by 9.8% for the three months ended December 31, 2025, driven by strong pricing strategies[44] Acquisitions and Costs - The acquisition of the Prime100 pet food business contributed 0.5% to the total company volume for the three months ended December 31, 2025[45] - The company reported acquisition-related costs of $9 million in 2025, with no such costs reported in 2024[58] - The restructuring program charges for 2025 were related to the Strategic Growth and Productivity Program and the 2022 Global Productivity Initiative[61] Non-GAAP Metrics - The company reported a non-GAAP net income of $1.038 billion for the three months ended December 31, 2025, a 22.9% increase from $800 million in 2024[54] - Colgate-Palmolive's GAAP gross profit for 2025 was $12,251 million, compared to $12,161 million in 2024, reflecting a slight increase[58] - The gross profit margin under GAAP decreased from 60.5% in 2024 to 60.1% in 2025, a change of -40 basis points[58] - Non-service related postretirement costs under GAAP decreased from $87 million in 2024 to $55 million in 2025[58]